Development of Kunming Pharmaceutical Group Co., Ltd.

Kunyao integrates drug research and development, production, sales, commercial wholesale and international marketing, and has formed a business pattern focusing on independent natural plant drugs, covering traditional Chinese medicine, chemical medicine, pharmaceutical circulation and other fields; It has four subsidiaries: Kunming Chinese Medicine Factory Co., Ltd., Yunnan Jintaide Sanqi Industry Co., Ltd., Xishuangbanna Pharmaceutical Co., Ltd. and Kunming Pharmaceutical Group Pharmaceutical Commercial Co., Ltd. 1 joint venture company: Kunming Baker Norton Pharmaceutical Co., Ltd., 1 manufacturing center, 1 pharmaceutical research institute, 1 postdoctoral workstation. The total assets are11900,000 yuan, and there are more than 3,000 employees, and various professional and technical personnel account for 65% of the total employees.

Relying on Yunnan's abundant plant resources and taking the road of internationalization and high-tech industrialization, Kunyao is the only natural medicine research, development, production and management enterprise in China. More than 40 new natural medicine products with advanced level at home and abroad, such as artemether series, notoginseng series, gastrodin series, characteristic Chinese medicine and characteristic ethnic medicine, have been developed successively, and have 16 national invention patents. The research and development, internationalization and industrialization of Kunming compound artemether won the second prize of national scientific and technological progress, and the technical transformation project of freeze-dried powder injection won the national high-tech industrialization demonstration project.

All formulations and APIs produced by Kunyao have passed the national GMP certification, and the workshop of artemether API has passed the four-fold certification of China National GMP, World Health Organization (WHO) GMP, Australian TGA and US FDA. After nearly 20 years of international market development, Kunming Pharmaceutical Co., Ltd. has exported artemether preparations to more than 40 countries and regions around the world, and has maintained the first export performance of single pharmaceutical preparations in China for 13 years.

Outstanding R&D strength, rich product variety resources, strong comprehensive manufacturing capability, quality management system conforming to international standards and international marketing team have become the core competitive advantages of Kunyao.

In the future development, Kunyao will take "Green Kunyao, Well-off Society" as its purpose, rely on Yunnan natural medicine resources, give full play to the core competitive advantages of the enterprise, continue to maintain its leading position in the pharmaceutical industry, and strive to become a well-known brand and outstanding representative of natural botanical medicines in the global pharmaceutical industry.